Zota Health Care Limited

NSE:ZOTA.NS

607.15 (INR) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32016 Q1
Revenue 563.006496.356469.314452.732386.482368.489349.659389.508291.914313.364310.248353.88334.438305.906304.827281.664175.496230.796250.638252.875216.819205.992217.647176.124
Cost of Revenue 506.11417.033382.097248.5236.865206.858214.381234.725176.733255.111184.885233.121219.956239.855214.035187.149116.432177.417178.635179.484149.951156.919153.307115.359
Gross Profit 56.89679.32387.217204.232149.617161.631135.278154.783115.18158.253125.363120.759114.48266.05190.79294.51559.06453.37972.00373.39166.86849.07364.3460.765
Gross Profit Ratio 0.1010.160.1860.4510.3870.4390.3870.3970.3950.1860.4040.3410.3420.2160.2980.3360.3370.2310.2870.290.3080.2380.2960.345
Reseach & Development Expenses 0000000000.0050000.2010001.0180000.91800
General & Administrative Expenses 0000049.58300033.99000-48.29900034.19400036.629014.802
Selling & Marketing Expenses 0000078.95300050.096000115.30600033.92500023.49605.007
SG&A 149.72162.161104.678100.12745.961128.536106.18978.73173.17584.08625.55323.35539.21467.00723.16623.68120.6568.11926.325.89924.35260.12522.83919.809
Other Expenses 0.1794.5681.5143.961.5190.2496.1738.406119.886-8.1013.3661.7763.036-9.8585.7152.112.308-9.3113.0743.7492.981-10.3931.7380
Operating Expenses 149.72162.161104.678207.948170.908190.067168.031135.1119.88672.70283.26679.00771.86472.623110.6793.65454.94246.64669.47962.40161.34233.16865.42339.465
Operating Income -92.824-82.838-17.4610.244-21.291-20.492-26.58128.0880.026-14.42642.09741.75245.463-8.676-19.8782.97-14.1629.9082.52314.7385.59919.5910.65521.342
Operating Income Ratio -0.165-0.167-0.0370.001-0.055-0.056-0.0760.0720-0.0460.1360.1180.136-0.028-0.0650.011-0.0810.0430.010.0580.0260.0950.0030.121
Total Other Income Expenses Net -28.8-12.243-9.874-11.361-6.806-10.448-7.088-6.631-3.7854.4833.2211.654-0.1450.0615.37310.14-0.3420.3282.844-0.102-0.231-2.335-0.145-0.151
Income Before Tax -121.624-95.081-27.335-11.117-28.097-30.939-33.66921.457-3.759-9.94345.31843.40645.567-8.615-14.50413.116.35610.2365.36814.6368.37717.2560.5121.191
Income Before Tax Ratio -0.216-0.192-0.058-0.025-0.073-0.084-0.0960.055-0.013-0.0320.1460.1230.136-0.028-0.0480.0470.0360.0440.0210.0580.0390.0840.0020.12
Income Tax Expense 5.614-25.9042.0485.4230.281-4.592-1.41512.3974.4270.20211.9111.28311.913-1.329-4.4262.9391.2513.1431.5663.7292.7615.757-2.2327.007
Net Income -127.239-69.177-29.384-16.54-28.378-26.348-32.2549.06-8.186-10.10933.40832.12333.654-7.285-10.07910.1715.1057.0913.80110.9075.61611.4992.74214.184
Net Income Ratio -0.226-0.139-0.063-0.037-0.073-0.072-0.0920.023-0.028-0.0320.1080.0910.101-0.024-0.0330.0360.0290.0310.0150.0430.0260.0560.0130.081
EPS -4.8-2.68-1.14-0.64-1.13-1.05-1.280.36-0.33-0.41.331.31.37-0.3-0.410.410.210.290.150.440.230.470.110.71
EPS Diluted -4.8-2.68-1.14-0.64-1.13-1.05-1.280.36-0.33-0.41.331.31.37-0.3-0.410.410.210.290.150.440.230.470.110.71
EBITDA -12.589-14.85133.33148.23614.30710.5716.43756.74919.1585.6453.30350.35851.901-0.051-6.15410.63313.82119.86710.40717.94311.51222.2264.36923.837
EBITDA Ratio -0.022-0.030.0710.1070.0370.0290.0180.1460.0660.0180.1720.1420.155-0-0.020.0380.0790.0860.0420.0710.0530.1080.020.135